Pressure BioSciences, Inc. (OTCQB: PBIO) Discovery Starts with - - PDF document

pressure biosciences inc
SMART_READER_LITE
LIVE PREVIEW

Pressure BioSciences, Inc. (OTCQB: PBIO) Discovery Starts with - - PDF document

Investor Presentation Pressure BioSciences, Inc. (OTCQB: PBIO) Discovery Starts with Sample Preparation Richard T. Schumacher President & CEO Jeffrey N. Peterson Board Chairman Vito Mangiardi, MBA Kevin A. Pollack, Esq., MBA


slide-1
SLIDE 1

Investor Presentation

Pressure BioSciences, Inc.

(OTCQB: PBIO)

Discovery Starts with Sample Preparation™

Richard T. Schumacher President & CEO Jeffrey N. Peterson – Board Chairman Vito Mangiardi, MBA Kevin A. Pollack, Esq., MBA Mickey Urdea, Ph.D.

December 12, 2013

slide-2
SLIDE 2

Forward Looking Statements

This presentation may contain forward looking statements that reflect management’s current views and opinions as to the status of the Company’s products, technology and

  • ther future events and operations. These statements are

neither a promise nor guarantee, but involve risks and uncertainties that could cause actual results to differ materially from those anticipated or indicated. Investors are cautioned that any forward looking statements should be considered in light of such risks and uncertainties including, without limitation, those detailed in the Company’s filings with the Securities and Exchange Commission.

2

slide-3
SLIDE 3

Management

  • Mr. Richard T. Schumacher, President & CEO

Boston Biomedica (CEO, Founder); Panacos Pharma (President, Co-founder); Trinity Biotech (Founding Group); CBR Labs (Gen’l Mgr) - Harvard Medical School

  • Dr. Edmund Y. Ting, Senior Vice President of Engineering

Avure Technologies (CSO); Flow Int’l (CSO); Grumman Aerospace; MIT (Ph.D.)

  • Dr. Alexander V. Lazarev, Vice President of R&D

Proteome Systems; Genomic Solutions; ESA; University of Kazan (Ph.D.)

  • Dr. Nathan P. Lawrence, Vice President of Marketing

Boston Biomedica; BD; Gene-Trak Systems; Yale University (Ph.D.)

  • Mr. Richard P. Thomley, Chief Financial Officer

Kiva Systems; SynQor; Catamount Manufacturing; ChemDesign Corp

Board

  • Jeffrey Peterson, MBA, Chairman
  • Kevin Pollack, Esq., MBA, Audit Committee Chairman

Experienced Senior Management & Board

slide-4
SLIDE 4
  • OTCQB: PBIO
  • Ten (10) Full-time Employees
  • Strong Management Team and Board of Directors
  • 24 Patents: Pressure Cycling Technology (PCT) Platform
  • Early Revenue: 2011 ($988K), 2012 ($1.2M), Q1–Q3 2013 ($1.15K)
  • 12.0M Common Shares & 8.0M Preferred Shares OS
  • Market Cap (fully diluted): $5.7 M
  • Development and Sale of PCT-based Products (Instruments and

Consumables) for the Preparation of Samples for Scientific Research

Company Overview

4

slide-5
SLIDE 5

What is a Biomarker?

Molecules (e.g., genes, proteins, lipids) found in tissue (e.g., cells) or body fluids (e.g., blood) that correlate – directly of indirectly – with the presence

  • r absence, the progression or recurrence, and the effects of treatment on

a disease or a disorder.

5

LDL Cholesterol (coronary heart disease) PSA (prostate cancer) Her-2/neu (breast cancer) Anti-HIV (AIDS infection)

Biomarker

Importance

slide-6
SLIDE 6

Estimated Market: Biomarker Discovery

WW Biomarker Market Est. to Reach $25.79B by 2016 -

2012 ASDReports 6

slide-7
SLIDE 7

Pressure Cycling Technology (PCT)

Release Important Biomolecules by Cell Lysis

7

slide-8
SLIDE 8

Scientific research can be broken down to three key elements: sample preparation, analysis, & data reduction/interpretation “Discovery Starts with Sample Preparation”

Sample Input Quality = Sample Result Quality

8

slide-9
SLIDE 9

Competitive Landscape

  • Mortar & Pestle
  • Dounce homogenizer (glass on glass)
  • Potter-Elvenhjem homogenizer (Teflon on glass)
  • Enzymatic Digestion
  • Polytron shearing homogenizers
  • Blenders
  • Bead Beating
  • Sonication
  • Repeated Freeze/Thaw cycles
  • French Press (≤ 2000 PSI)

Mostly Commodity Products Through Catalogue Sales

9

slide-10
SLIDE 10

Barocycler™ NEP2320 PCT Sample Preparation System Barocycler™ NEP3229

10

PULSE Tube MicroTubes PCT-dependent Kits

slide-11
SLIDE 11

Next Gen PCT Platform: HUB Family of Barocyclers

High Pressure Generators

for Multiple Research & Mfg Applications

  • Compact
  • Portable
  • Versatile
  • Computer Controlled
  • Labview Software Driven
  • Pressures to:
  • 20 kpsi (HUB160) 2012
  • 60 kpsi (HUB440) 2012
  • 100 kpsi (HUB880) 2014

11

…the HUB for every laboratory’s high pressure needs via state-of-the-art, application specific modules & software

slide-12
SLIDE 12

The Shredder SG3

The Shredder SG3

Low Shear, Mechanical, Homogenization Device

Long lasting lithium rechargeable batteries Paddle for convenient pressure setting Pressure force levels: 15, 30, 45 lbs. Force Uses PCT PULSE and Shredder Tubes Heavy Duty, Robust Driver

12

slide-13
SLIDE 13

Selected Marquee Customers (40 of 150)

  • Amgen
  • Biogen
  • Lilly
  • Novartis
  • Monsanto
  • BM Squibb
  • Merck
  • Centocor
  • Takeda Pharmaceuticals
  • Momenta Pharmaceuticals
  • US Army
  • FBI
  • Food and Drug Administration
  • US Department of Agriculture
  • National Institutes of Health
  • Armed Forces Inst. of Pathology
  • Thermo Fisher
  • Target Discovery
  • Battelle Memorial Institute
  • Harvard Medical School
  • Harvard School of Public Health
  • Rockefeller University
  • University of New Hampshire
  • Barnett Research Inst (NEU)
  • UCLA
  • UC - San Diego
  • UC - Davis
  • Lawrence Livermore
  • Stanford University
  • University of North Texas
  • Mississippi State
  • Montana State
  • Lawrence Berkeley

13

slide-14
SLIDE 14

Professor Wayne Hubbell - UCLA

"Protein flexibility is the new frontier in understanding protein function and regulation. The study of proteins under pressure has great ability to reveal salient features of protein flexibility, and hence provide new insights into protein function and rational drug design. In my opinion, high pressure will play a central role in the discovery process that lies ahead in the exciting field of protein science, and the PBI hardware will make major contributions to this field.” December, 2012

14 Distinguished Professor of Chemistry & Biochemistry, and Jules Stein Professor at UCLA

slide-15
SLIDE 15
  • Dr. Henry C. Lee

“We are excited about this opportunity to collaborate with Pressure BioSciences to examine the potential applications of their PCT Platform in improving the collection of forensic evidence, particularly DNA, in several important areas of forensics…such collaborations not only provide new, effective technologies for forensic DNA testing of samples that have been difficult or unsuitable using today’s standard techniques, but can also provide new and more effective ways to reexamine old biological evidence in cold cases.”

15

Professor of Forensic Science and founder of the Forensic Science Program at the University of New Haven; founder of the HC Lee Institute of Forensic Sciences; and former Commissioner of Public Safety for the State of Connecticut.

slide-16
SLIDE 16

PCT Focus Area: Biomarker Discovery

  • Dr. Andreas Huhmer – Thermo Fisher Scientific

…advantages of speed and quality using PCT in mass spec workflow

  • Dr. Michael Alterman – Tumor Vaccines and Biotechnology Branch, CBER, FDA

…improved influenza vaccine quality using PCT in mass spec workflow

  • Dr. Alexander Ivanov – Harvard School of Public Health

…improved membrane protein identification using PCT in mass spec workflow

  • Dr. Bruce McCord, Florida International University

…improved processing of forensic (rape kit) samples using PCT

  • Dr. Luke Schneider, Target Discovery, Inc.

…improved membrane protein recovery in ovarian cancer studies using PCT in mass spec workflow

  • Dr. Bruce Budowle, Health Science Center, University of North Texas

…improved detection of DNA in forensic samples using PCT

Cancer, Heart Disease, Inf. Diseases, Neurological Disorders, Forensics, Etc.

  • Dr. Henry C. Lee, the Henry C. Lee Institute of Forensic Science

…evaluation of PCT in the recovery and detection of DNA in difficult forensic samples

  • Dr. Jeff Mason and Dr. Carol Fowler, Armed Forces Institute of Pathology

...improved processing of FFPE (histology) samples using pressure

  • Dr. Jennifer Van Eyk, Johns Hopkins School of Medicine

…improved recovery of aorta proteins from FFPE samples using PCT 1 6

slide-17
SLIDE 17
  • Analysis of DNA, RNA, Proteins, & Lipids (“biomolecules”) is

Crucial to the Discovery of New Biomarkers

  • The Quality of Results of Biomolecule Analyses Depends Significantly
  • n the Quality of the Preparation of the Sample
  • Current Sample Preparation Methods are Highly Inadequate:

bottleneck

  • Over 100 Publications Now Highlight the Clear Advantages of PCT

Over Current Competitive Products

  • Multi-Billion Market Opportunity for Biomarker Discovery Products
  • ~ 500K Scientists in ~ 80K Labs WW work in biological research labs
  • New, First-in-Kind High Pressure Generator – can go to 100,00 psi

Value Proposition: PCT & Biomarker Discovery

1 7

slide-18
SLIDE 18

2014 Potential Driver: Barocycler HUB880

1 8

  • 7000 Bar (100,000 psi) max pressure- same as in M1 tank 120mm gun chamber !
  • Newest addition to HUB family of pressure generators
  • Targeted at HP protein, bacteria, spore, and virus research
  • Also basic material (polymer, fluids) compression characterization

First Delivery Unit

slide-19
SLIDE 19

June 2013 Technology Breakthrough

Manual to High Throughput PCT

From Dream to Reality

Manual Processing of Automated Processing of Multiple (24-96)

Individual (1-48) Sample Tubes Sample Tubes (wells) Simultaneously

1 9

slide-20
SLIDE 20

High Throughput Screening of Samples

Automated liquid handling helps ensure accuracy and reproducibility,

eliminates repetitive tasks, and frees personnel for other activities.

2

LEAP Technologies

slide-21
SLIDE 21

2H 2014 Potential Driver: High Throughput PCT

2 1

Holder for Standard “PCR” sample (9mm) plate design (up to 6 strips of 8 wells)

“Barozyme” instrument

  • Initial Application:

– High pressure accelerated digestion

  • Consumable:

– Proprietary PBI 8 well strips

  • Max Number of Samples:

– 48 (2X3X8) samples

  • User Control:

– Touch screen

slide-22
SLIDE 22

PressureFlex™ Micro-wells

Fill the sample wells and place a silicone cap

  • ver

mPFwell. Up to 3 strips can be loaded on a support plate. Install retention spring clip

  • ver tubes

and support plate. Samples are now in support plate and ready to be loaded into the carrier. 1 4 3 2

2 2

slide-23
SLIDE 23

Barozyme Sample Carrier

Open empty carrier. Insert support plate with samples into carrier. Latch cover and close. Load side 2 with an additional 3 strips of samples if needed. Carrier with up to 48 sample wells now ready to be placed into the pressure chamber. 1 2 3 4

Side 1 Side 2

OK to go!

2 3

slide-24
SLIDE 24

PBI Barozyme™ Sample Carrier

PressureFlex™ strips are the only “PCR” type strip that allow hydrostatic pressure to be easily transmitted into the sample. The samples remain leak free even under repeated 20,000 psi hydrostatic pressure cycles. Up to 6 PressureFlex™ mwell strips are nested for a total of 48 samples per carrier.

2 4

slide-25
SLIDE 25

2H 2014 Potential Driver: High Throughput PCT

2 5

PCT-based, High Throughput, “Barozyme” instrument

slide-26
SLIDE 26

High Throughput Screening of Samples

Automated liquid handling helps ensure accuracy and reproducibility,

eliminates repetitive tasks, and frees personnel for other activities.

2 6

LEAP Technologies

slide-27
SLIDE 27
  • Nov 7th: Reported Record Quarterly (Q3) and YTD Total Product Revenue,

Including Record Quarterly (Q3) and YTD Consumables Sales

  • Aug 1st: UCLA Scientists Presented Data on an Advanced Pressure-based

Instrument System for Biomarker Discovery

  • June 14th: Announced Final Closing of a $2 Million Above Market PIPE
  • June 4th: Announced Core Technology Breakthrough (novel multiwell format)
  • May 16th: Reported on the Development of a Novel, Non-invasive

Pressure-based Method for Lipid Analysis (Dr. Kristal – Boston)

  • April 4th: Announced that Advances Made in Improving Rape Kit Testing

Using PBI’s PCT Platform (Dr. McCord - FIU)

  • March 19th: Announced that the Advantages of the PCT Platform had been

Highlighted at Int’L Protein Conference (cancer, stem cell, heart)

Significant Achievements: 2013

27

slide-28
SLIDE 28
  • Pressure Cycling Technology (PCT): Powerful, Enabling, Patented
  • PCT Represents the Next Generation Platform for Biomarker Discovery
  • PCT Products Offer Significant Advantages Over Competitive Methods
  • Proven Technology: ~ 250 Installations in ~150 Marquee Laboratories
  • Attractive “Razor/Razorblade” Business Model
  • On-going Discussions with Large Potential Strategic Partners
  • Experienced Management Team and Board of Directors
  • Favorable Market Valuation for the Investor
  • Large (estimated $6 Billion) Market Opportunity
  • Strong FY 2013 through Q3; Guidance for Strong Q4; Revenue Growth

Expected to Continue into 2014

  • Recent Technological Breakthrough (HT Barocycler), Impending HUB880 Release,

New Consumables, Increased Distribution Network, and Existing Proven Products, Offer the Potential to Rapidly and Significantly Accelerate Growth in 2014 and Beyond

Key Investment Highlights

28